Published

Psychedelics and women's mental health: the effects of female sex hormones on psychedelics' efficacy and tolerability.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Molecular Psychiatry
Date: 2026-08-03
Source: Europe PMC
DOI: 10.1038/s41380-026-03801-2
PubMed: 42552418

Authors

Kuypers KPC Mason NL Carlier A Totomanova I Haijen-Bongers ECHM.

Watch author

Derived topics and classifications

psilocin Depression Anxiety Brain Imaging Pharmacology Mechanism of Action Receptor Pharmacology Aging Longevity Review Article Animal Study Safety Review Article

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Psychedelics and women's mental health: the effects of female sex hormones on psychedelics' efficacy and tolerability.2026-08-03

Related papers

Editorial: Psychedelic-assisted psychotherapies: from clinical trials to credibilityFrontiers in Neuroscience · 2026-03-22 Psychedelics and mental health: reimagining care through science, insight, and compassionFrontiers in Pharmacology · 2025-09-02 Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric DisordersPsychiatry and Clinical Psychopharmacology · 2026-03-29 Editorial: Psychedelic substances and neurological diseases: from basics to clinical applicationFrontiers in Pharmacology · 2026-03-15 Novel perspectives for glutamatergic strategies, psychedelics and antipsychotic augmentation in Treatment Resistant Depression: A narrative reviewClinical Neuropsychopharmacology and Addiction · 2025-09-24 Contribution of the Serotonin 5-HT2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat StressNeuropsychopharmacology Reports · 2026-08-31 Estimating Cardiac 5-HT2B Safety Margins for Repeated Low-Dose Psilocybin Using an Exposure-Response ModelbioRxiv · 2026-07-22 From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical PracticePharmacology Research & Perspectives · 2026-05-09